Statistically conclusive or suggested result Inconclusive results Uncertain results Safety results

mHCC - (neo)adjuvant (NA) metastatic/advanced hepatocellular cancer (mHCC) mHCC - (neo)adjuvant (NA)

versus nivolumab alone
nivolumab plus ipilimumab vs. nivolumab alone 1